3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pain, Postoperative
4
Breast Neoplasms
4
Liver Neoplasms
2
Colonic Neoplasms
2
Chronic Pain
2
Carcinoma, Non-Small-Cell Lung
2
Supratentorial Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms
1
Postoperative Hemorrhage
1
Pilonidal Sinus
1
Pancreatic Neoplasms
1
Pain
1
Oropharyngeal Neoplasms
1
Opioid-Related Disorders
1
Nevus, Pigmented
1
Neuroma
1
Neuralgia
1
Neoplasms
1
Melanoma
1
Malignant Pleural Neoplasm
1
Lung Neoplasms
1
Localised Prostate Cancer
1
Leiomyoma
1
Ileus
1
Hordeolum
1
Glioblastoma
1
Eyelid Neoplasms
1
Colorectal Neoplasms
1
Interventions
pembrolizumab
5
enfortumab vedotin
3
Gemcitabine
3
dodecyl maltoside
2
Sunitinib
2
Cisplatin
2
zidovudine 5'-monophosphate-mannose-albumin conjugate
1
tucatinib
1
testosterone 17 beta-cypionate
1
temsirolimus
1
relatlimab
1
palbociclib
1
niraparib
1
galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20
1
cabozantinib
1
Valproic Acid
1
Urinary Diversion
1
Trastuzumab
1
Testosterone Propionate
1
Standard of Care
1
Sirolimus
1
Rivaroxaban
1
Ringer's acetate
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Psychiatric Nursing
1
Practice Guidelines as Topic
1
Physical Therapy Modalities
1
Nivolumab
1
Multiparametric Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urologic Neoplasms
×
Lidocaine
×
1 year
×
Clear all
No trials found.